Arizona State Retirement System’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-33,379
Closed -$67K 2325
2022
Q1
$67K Buy
33,379
+3,103
+10% +$6.1K ﹤0.01% 2198
2021
Q4
$82K Buy
30,276
+3,217
+12% +$11.9K ﹤0.01% 2238
2021
Q3
$121K Buy
27,059
+66
+0.2% +$318 ﹤0.01% 2162
2021
Q2
$157K Buy
26,993
+2,569
+11% +$15.1K ﹤0.01% 2165
2021
Q1
$171K Buy
24,424
+154
+0.6% +$1.03K ﹤0.01% 2065
2020
Q4
$116K Sell
24,270
-952
-4% -$4.82K ﹤0.01% 2059
2020
Q3
$147K Buy
25,222
+6,355
+34% +$38K ﹤0.01% 1868
2020
Q2
$127K Buy
+18,867
New +$143K ﹤0.01% 1751

Other funds holding CLVS

Arizona State Retirement System's CLVS Position: Q2 2022 in Review

Arizona State Retirement System sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 33,379 shares — an estimated $67K sold.

Arizona State Retirement System first reported a position in CLVS in Q2 2020 and held it in 8 quarters. The position peaked at $171K in Q1 2021. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

  • Arizona State Retirement System reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
  • Arizona State Retirement System sold 33,379 Clovis Oncology, Inc. shares in Q2 2022, an estimated $67K.
  • Arizona State Retirement System first reported a position in Clovis Oncology, Inc. in Q2 2020 and held it in 8 quarters.
  • Arizona State Retirement System's Clovis Oncology, Inc. position peaked at $171K in Q1 2021.
  • 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on Arizona State Retirement System's 13F filing for Q2 2022, filed 28 Jul 2022.